Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PG(42:10) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 9.98 | pmol/sample |
| - | PG(42:10) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 10.9 | pmol/sample |
| - | PG(42:10) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 7.92 | pmol/sample |
| - | PG(42:10) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 24.9 | pmol/sample |
| - | PG(42:10) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 25.4 | pmol/sample |
| - | PG(42:10) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 20.2 | pmol/sample |
| - | PG(42:10) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 13.6 | pmol/sample |
| - | PG(42:10) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 8.21 | pmol/sample |
| - | PG(42:10) | C | 0.0 | BCD100322A01 | 15.7 | pmol/sample |
| - | PG(42:10) | C | 0.5 | BCD100322A03 | 7.4 | pmol/sample |
| - | PG(42:10) | C | 1.0 | BCD100322A07 | 8.25 | pmol/sample |
| - | PG(42:10) | C | 2.0 | BCD100322A11 | 9.18 | pmol/sample |
| - | PG(42:10) | C | 4.0 | BCD100322A15 | 24.5 | pmol/sample |
| - | PG(42:10) | C | 8.0 | BCD100322A19 | 25.1 | pmol/sample |
| - | PG(42:10) | C | 12.0 | BCD100322A23 | 24 | pmol/sample |
| - | PG(42:10) | C | 24.0 | BCD100322A27 | 5.05 | pmol/sample |
| - | PG(42:10) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 5.65 | pmol/sample |
| - | PG(42:10) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 6.87 | pmol/sample |
| - | PG(42:10) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 15.9 | pmol/sample |
| - | PG(42:10) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 25.9 | pmol/sample |
| - | PG(42:10) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 22.4 | pmol/sample |
| - | PG(42:10) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 5.14 | pmol/sample |
| - | PG(42:10) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 3.06 | pmol/sample |
| - | PG(42:10) | 25OH-Chol | 0.5 | BCD100322A04 | 7.97 | pmol/sample |
| - | PG(42:10) | 25OH-Chol | 1.0 | BCD100322A08 | 10.9 | pmol/sample |
| - | PG(42:10) | 25OH-Chol | 2.0 | BCD100322A12 | 15.2 | pmol/sample |
| - | PG(42:10) | 25OH-Chol | 4.0 | BCD100322A16 | 25.6 | pmol/sample |
| - | PG(42:10) | 25OH-Chol | 8.0 | BCD100322A20 | 23.1 | pmol/sample |
| - | PG(42:10) | 25OH-Chol | 12.0 | BCD100322A24 | 20.9 | pmol/sample |
| - | PG(42:10) | 25OH-Chol | 24.0 | BCD100322A28 | 3.76 | pmol/sample |